|
Mar 7
|
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 20.8% Since Last Earnings Report?
|
|
Mar 5
|
11 Best Small Cap Pharma Stocks to Invest In
|
|
Jan 5
|
Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18
|
|
Jan 2
|
Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 15
|
Deciphera Pharmaceuticals CEO Steven Hoerter Sells Over 30,000 Shares
|
|
Dec 8
|
Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Intrinsic Value Is Potentially 97% Above Its Share Price
|
|
Dec 2
|
Insider Sell Alert: Daniel Martin of Deciphera Pharmaceuticals Inc Cashes Out Shares
|
|
Dec 1
|
Exelixis (EXEL) Up 8.4% Since Last Earnings Report: Can It Continue?
|
|
Nov 30
|
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?
|
|
Nov 29
|
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 1.7% Since Last Earnings Report?
|
|
Nov 29
|
Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
|
|
Oct 5
|
Deciphera Pharmaceuticals (DCPH): A Closer Look at Its Undervalued Status
|
|
Sep 8
|
Deciphera Pharmaceuticals, Inc. (DCPH) Down 9.7% Since Last Earnings Report: Can It Rebound?
|
|
Apr 27
|
Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Apr 26
|
Will Deciphera Pharmaceuticals, Inc. (DCPH) Report Negative Q1 Earnings? What You Should Know
|
|
Apr 26
|
Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023
|